Skip to content

Post Holdings POST Indefinite- lived intangible impairment

Indefinite- lived intangible impairment at other companies

Mondelez International logo
Mondelez InternationalMDLZ
$22.04B+2.8%
Cal-Maine Foods logo
Cal-Maine FoodsCALM
The J.M. Smucker Company logo
The J.M. Smucker CompanySJM
Lamb Weston logo
Lamb WestonLW
Central Garden & Pet Company logo
Central Garden & Pet CompanyCENT
Chewy logo
ChewyCHWY

Other financials

Income statement

See full
Revenue$2.0B+4.7%
Gross profit$617.6M+13.2%
Operating income$211.9M+16.3%
Net income$81.9M+30.8%
EPS (diluted)$1.56+51.5%

Balance sheet

See full
Cash & equivalents$271.4M-56.6%
Total debt$7.7B+10.0%
Total equity$3.2B-16.6%
Total assets$13.0B+1.4%

Cash flow

See full
Operating cash flow$242.3M+50.8%
CapEx$91.3M+0.9%
Free cash flow$151.0M+115%

Valuation

See full
Market cap$4.03B-27.9%

Profitability

See full
Gross margin29.1%0.0pp
Operating margin10.1%+0.1pp
Net margin4%-0.5pp
FCF margin6.1%-0.2pp

Returns & leverage

See full
Return on equity9.6%+0.5pp
Debt / equity2.4×+0.6×
Current ratio1.9×-0.3×

Where this comes from

Reported directly by Post Holdings in its filing.

Tagged under the XBRL concept us-gaap:IntangibleAssetsGrossExcludingGoodwill.

The official record: Post Holdings’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Post Holdings's indefinite- lived intangible impairment.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Post Holdings's indefinite- lived intangible impairment?
Post Holdings (POST) reported indefinite- lived intangible impairment of $4.47B in Q1 2026.
How has Post Holdings's indefinite- lived intangible impairment changed year-over-year?
Post Holdings's indefinite- lived intangible impairment decreased by 2.1% year-over-year, from $4.57B to $4.47B.
What is the long-term trend for Post Holdings's indefinite- lived intangible impairment?
Over 5 years (2020 to 2025), Post Holdings's indefinite- lived intangible impairment has grown at a 2.3% compound annual growth rate (CAGR), from $4.15B to $4.65B.